ANI Pharmaceuticals Inc

Company Snapshot
210 Main Street West
Baudette, MN 56623
United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 600
https://www.anipharmaceuticals.com
Please select from the dropdown
  1. Executive Compensation
  2. > ANI Pharmaceuticals Inc
Company Financials

2021
2022
2023
Gross Profit
$115,526,000
$177,600,000
$305,303,000
Operating Income
-$28,169,000
-$25,734,000
$49,529,000
Net Income
-$42,603,000
-$47,896,000
$18,779,000
2021
Gross Profit
$115,526,000
Operating Income
-$28,169,000
Net Income
-$42,603,000
2022
Gross Profit
$177,600,000
Operating Income
-$25,734,000
Net Income
-$47,896,000
2023
Gross Profit
$305,303,000
Operating Income
$49,529,000
Net Income
$18,779,000
The above data on ANI Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Nikhil Lalwani
Director, President and Chief Executive Officer
$2,309,011
$5,756,142
$13,200
$8,078,353
Nikhil Lalwani
$8,078,353
Director, President and Chief Executive Officer
Stephen Carey
Senior Vice President Finance, Principal Accounting Officer and Chief Financial Officer
$1,094,146
$1,465,142
$16,800
$2,576,088
Stephen Carey
$2,576,088
Senior Vice President Finance, Principal Accounting Officer and Chief Financial Officer
Ori Gutwerg
Senior Vice President Generics
$895,158
$1,046,532
$0
$1,941,690
Ori Gutwerg
$1,941,690
Senior Vice President Generics
Christopher Mutz
Senior Vice President and Head of Rare Diseases
$852,530
$1,046,532
$15,389
$1,914,451
Christopher Mutz
$1,914,451
Senior Vice President and Head of Rare Diseases
Chad Gassert
Senior Vice President Corporate Development and Strategy
$842,356
$1,046,532
$7,355
$1,896,243
Chad Gassert
$1,896,243
Senior Vice President Corporate Development and Strategy
ANI Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us